105 filings
Page 5 of 6
8-K
df2klma1v
4 Nov 21
Other Events
4:02pm
8-K
qt7go
2 Nov 21
Talaris Therapeutics Announces Initiation of Phase 2 Clinical Trial of FCR001 in Delayed Tolerance Induction
4:02pm
8-K
sk2i1fno
12 Aug 21
Talaris Therapeutics Announces Second Quarter 2021 Financial Results and Provides Business Update
10:35am
10-Q
e815mr8
14 Jun 21
Quarterly report
4:21pm
8-K
43glpjrd pkq78i
14 Jun 21
Talaris Therapeutics Announces First Quarter 2021 Financial Results and Provides Business
4:07pm
8-K
2ir lkjyjrrm
11 May 21
Amendments to Articles of Incorporation or Bylaws
4:00pm
424B4
5juad0
10 May 21
Prospectus supplement with pricing info
4:20pm
EFFECT
xxhftconrhp4
7 May 21
Notice of effectiveness
12:15am
S-8
bhjzjwy69kl
6 May 21
Registration of securities for employees
4:37pm
CERT
7y7yhn6ddfoovfpe
6 May 21
Certification of approval for exchange listing
4:31pm
SEC STAFF
25phvgia5a00htn
6 May 21
SEC staff action: Order
12:00am
UPLOAD
3c8a4nzxwupait5f8k
5 May 21
Letter from SEC
12:00am
8-A12B
g67wtp6 5i
4 May 21
Registration of securities on exchange
4:04pm
CORRESP
hn5vivi1g72klxaz0 he
4 May 21
Correspondence with SEC
12:00am
CORRESP
opipdg
4 May 21
Correspondence with SEC
12:00am
S-1/A
5mkj k1liv
3 May 21
IPO registration (amended)
6:07am
S-1
6b8nm
16 Apr 21
IPO registration
5:03pm
CORRESP
hucth95o
16 Apr 21
Correspondence with SEC
12:00am
SEC STAFF
or4mif1o6tgrgr
7 Apr 21
SEC staff action: Order
12:00am